Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avant Technologies Inc (AVAI)

Avant Technologies Inc (AVAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2799 +5.43%
on 12/02/25
0.4498 -34.39%
on 11/11/25
-0.0939 (-24.14%)
since 11/04/25
3-Month
0.2799 +5.43%
on 12/02/25
0.4500 -34.42%
on 10/21/25
-0.0730 (-19.83%)
since 09/04/25
52-Week
0.2191 +34.69%
on 03/06/25
0.8400 -64.87%
on 01/24/25
-0.2549 (-46.35%)
since 12/04/24

Most Recent Stories

More News
Stocks in play: Avant Technologies Inc

Announced that its 50/50 joint venture with Austrianova has entered into an exclusive, worldwide License ...

AVAI : 0.2951 (-1.63%)
Metabolic Reset: Cell Therapies and Novel Drugs Reshape Chronic Disease Market

VANCOUVER – Baystreet.ca News Commentary – The metabolic disorder therapeutics market projects growth to $120.7 billion by 2030 as biotechnology firms pioneer organ-level treatments addressing diabetes,...

AVAI : 0.2951 (-1.63%)
TNDM : 20.71 (+3.91%)
CRNX : 47.42 (+0.94%)
MDGL : 586.21 (+1.09%)
ALT : 5.31 (+3.91%)
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:NTLA),(NASDAQ:ZYME),(NYSE:ANVS) EQNX::TICKER_END

AVAI : 0.2951 (-1.63%)
ANVS : 4.65 (unch)
RXRX : 4.92 (+5.58%)
ZYME : 26.52 (+1.14%)
NTLA : 9.74 (+7.51%)
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

MarketNewsUpdates News Commentary NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The advance anti-aging therapies market is expanding quickly fueled by a larger senior population and increased...

AVAI : 0.2951 (-1.63%)
ANVS : 4.65 (unch)
RXRX : 4.92 (+5.58%)
ZYME : 26.52 (+1.14%)
NTLA : 9.74 (+7.51%)
Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies

Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced...

AVAI : 0.2951 (-1.63%)
Stocks in play: Avant Technologies Inc

Announced the formation of a groundbreaking Joint Venture and License Agreement aimed at revolutionizing ...

AVAI : 0.2951 (-1.63%)
Biologics Market Surges Toward $680B as FDA Accelerates Approval Pathways

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges toward $679.56...

AVAI : 0.2951 (-1.63%)
VRTX : 457.36 (-1.25%)
WST : 281.77 (-0.89%)
RCKT : 3.42 (+2.40%)
AXSM : 148.04 (+0.16%)
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and SGAustria Pte. Ltd. (SGAustria), a Singapore-based biotechnology company, today announced the formation...

AVAI : 0.2951 (-1.63%)
Stocks in play: Avant Technologies Inc

Today announced the official launch of their joint venture, Klothonova LLC, and its groundbreaking Klotho ...

AVAI : 0.2951 (-1.63%)
Healthcare's Shift to Prevention Gains Momentum as Markets Reach Critical Mass

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Longevity science advances reveal how genes from supercentenarians can reverse cardiac aging[1], while...

HUM : 253.02 (-1.52%)
AVAI : 0.2951 (-1.63%)
CRSP : 58.18 (+3.91%)
VRTX : 457.36 (-1.25%)
MNKD : 5.71 (+2.15%)

Key Turning Points

3rd Resistance Point 0.3112
2nd Resistance Point 0.3080
1st Resistance Point 0.3015
Last Price 0.2951
1st Support Level 0.2918
2nd Support Level 0.2886
3rd Support Level 0.2821

See More

52-Week High 0.8400
Fibonacci 61.8% 0.6028
Fibonacci 50% 0.5295
Fibonacci 38.2% 0.4563
Last Price 0.2951
52-Week Low 0.2191

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar